Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

688.92
-1.1468-0.17%
Number of Gainers:53
Number of Losers:89
Number of Flat:12
PE:- -
High:697.00
Open:688.41
Low:678.48
Close:690.06
Volume:328.22M
Turnover:8.65B
Market Cap:479.34B
Float Cap:364.87B

Loading ...

UiPath initiated with a Buy at Citi

TIPRANKS
·
Sep 08

Global-E President Debbi Nir Disposes of 228 Shares Worth $8,940.11

Reuters
·
Sep 08

Analysts Offer Insights on Financial Companies: Robinhood (HOOD) and JPMorgan Chase (JPM)

TIPRANKS
·
Sep 08

BTIG Adjusts Price Target on AppLovin to $396 From $408, Keeps Buy Rating

MT Newswires Live
·
Sep 08

Waterdrop Inc. Reports Q2 Results with AI-Driven Growth Momentum

Stock News
·
Sep 08

Robinhood price target raised to $142 from $124 at Goldman Sachs

TIPRANKS
·
Sep 08

Robinhood AMC tokens expose limits of short squeezes

cryptonews
·
Sep 08

FTC Solar to Hold Investor Meetings at H.C. Wainwright Conference

Reuters
·
Sep 08

Zhihu Proposes Subscription in AI Investment Fund

MT Newswires Live
·
Sep 08

Climb Bio, Inc. : H.c. Wainwright Raises Target Price to $30 from $24

THOMSON REUTERS
·
Sep 08

China's Waterdrop Inc Q2 Revenue Jumps 72.8% on Insurance Income Growth

Reuters
·
Sep 08

Beam Therapeutics’ BEAM-302 shows efficacy in Phase 1/2 AATD trial

TIPRANKS
·
Sep 08

Waterdrop Q2 Adj. EPS $0.05 Down From $0.06 YoY, Sales $213.441M Up From $116.975M YoY

Benzinga Earnings
·
Sep 08

HCW Biologics Announces Special Shareholder Meeting

Reuters
·
Sep 08

Waterdrop Q2 FY26 Net Profit Attributable to Shareholders Falls to RMB 125.8 Million; Revenue Rises 72.8% Year-over-Year to RMB 1.45 Billion

Reuters
·
Sep 08

Courtois S.A. Details Share Capital and Voting Rights Structure

TIPRANKS
·
Sep 08

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

GlobeNewswire
·
Sep 08

Press Release: Waterdrop Inc. Announces Second Quarter 2026 Unaudited Financial Results and a Cash Dividend

Dow Jones
·
Sep 08

Goldman Sachs Adjusts Price Target on Robinhood Markets to $142 From $124, Keeps Buy Rating

MT Newswires Live
·
Sep 08

UiPath, Inc. : Barclays Raises Target Price to $17 from $14

THOMSON REUTERS
·
Sep 08